Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Open in API
Filings indexed 509 across all filing types
Latest filing 2024-10-28 Proxy Solicitation & In…
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
General Meeting - Sample Proxy 2 pages 197.9KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Proxy Voting Form for a General Meeting of InhaleRx Limited scheduled for 28 November 2024. It includes instructions for shareholders on how to appoint a proxy, voting directions on specific resolutions related to share issues to directors and ratification of prior share issues, and details on submitting the proxy form. The content is focused on soliciting shareholder votes for resolutions at a meeting, which is characteristic of proxy solicitation materials. There is no financial data, management discussion, or report content. The document is not a report itself but a form used to facilitate voting at a shareholder meeting. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI).
2024-10-28 English
Notice of General Meeting 24 pages 449.6KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'NOTICE OF GENERAL MEETING' and contains detailed agenda items for shareholder resolutions, including the issue of shares to directors in lieu of director fees, ratification of prior share issues, and approval to issue options under a facility agreement. It includes voting exclusion statements, proxy voting instructions, and explanatory statements related to the resolutions. The content is typical of a notice sent to shareholders to inform them of the business to be conducted at a general meeting and to solicit their votes. There are no financial statements, audit opinions, or earnings data presented, nor is this a transcript or presentation. The document is not a report but a meeting notice with resolutions to be voted on. Therefore, the appropriate classification is 'Proxy Solicitation & Information Statement (PSI)', which covers materials sent to shareholders to provide information and request votes for meetings.
2024-10-28 English
General Meeting - Access Letter 1 page 123.7KB
AGM Information Classification · 95% confidence The document is a letter dated 28 October 2024 from the company to shareholders announcing the convening of an Annual General Meeting (AGM) scheduled for 28 November 2024. It provides details about the meeting format (online-only), proxy voting instructions, and where to find the Notice of Meeting and Explanatory Statement. The document does not contain the actual AGM materials or minutes but serves as an announcement and invitation to the AGM. The document length is short (1712 characters), and it explicitly states that the Notice of Meeting is available for download elsewhere, indicating this is not the AGM materials themselves. Therefore, this document fits the category of AGM Information (AGM-R) as it relates to the AGM event and information shared with shareholders about attending and voting.
2024-10-28 English
Change in substantial holding 4 pages 1.1MB
Regulatory Filings
2024-10-27 English
Application for quotation of securities - IRX 6 pages 18.4KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form titled 'Application for quotation of securities' for Inhalerx Limited. It details the application to quote securities on the ASX, referencing a previous Appendix 3B announcement about a securities issue. The document includes specifics about the number and type of securities to be quoted, issue dates, and issued capital following quotation. This type of document is a formal announcement related to capital market activities, specifically the quotation of securities following a prior issue. It is not a financial report, earnings release, or management discussion. It fits the category of Share Issue/Capital Change announcements, which cover new share issues and related capital changes.
2024-10-23 English
Proposed issue of securities - IRX 5 pages 17.4KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and details a proposed placement or other type of securities issue by Inhalerx Limited. It includes specifics such as the number of securities to be issued, the issue date, consideration details, and compliance with ASX Listing Rules. There is no financial performance data, earnings information, or management discussion. The content is focused on the announcement of a capital raising event through securities issuance. This matches the definition of a Capital/Financing Update (CAP). The document length is over 6000 characters and contains detailed information about the securities issue, not just a brief announcement or reference to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is CAP with high confidence.
2024-10-22 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.